Facial Eczema: Why Your Face Needs Different Care

Facial Eczema: Why Your Face Needs Different Care
By Jessica Arenas, Lead Research Analyst •

Eczema (atopic dermatitis) affects approximately 20% of children worldwide[46]. When it appears on the face, it creates unique treatment challenges. Research shows that facial skin has fundamentally different barrier properties than body skin[1]. This requires specialized approaches that many patients never learn about. Understanding these differences could transform how you manage facial flare-ups.

The visible nature of facial eczema creates challenges beyond physical discomfort. Studies document that facial involvement significantly impacts quality of life more than eczema on other body areas[2]. You've likely tried multiple moisturizers, avoided certain cosmetics, and dealt with questions about your skin. Research indicates that 67% of facial eczema patients report social anxiety related to their condition[3]. Your frustration with treatments that work elsewhere but fail on facial skin makes perfect sense. Facial skin truly is different.

This guide reveals why facial eczema requires unique treatment strategies. Recent dermatological research explains how facial skin's thinner barrier and environmental exposure affect treatment success[4]. You'll discover evidence-based approaches for facial eczema challenges. This includes microbiome management strategies proven to reduce flare frequency by up to 65%[5]. Plus, you'll learn about identifying your personal triggers to prevent future facial flares. Every recommendation comes from peer-reviewed research, not marketing claims.

Research reveals key differences in atopic dermatitis skin. It displays reduced natural moisturizing factors and altered lipid composition[6]. These changes contribute to dry skin and barrier dysfunction. This explains why facial eczema presents unique treatment challenges.

Key Takeaways

  • Facial skin barrier differs significantly - requires specialized treatment approaches
  • 70-100% of facial eczema lesions contain S. aureus - microbiome management crucial
  • Environmental triggers more impactful on face - prevention strategies essential
  • Natural remedies show promise - coconut oil and oatmeal have clinical evidence
  • Combination therapy most effective - barrier repair plus anti-inflammatory treatment

Table of Contents

Understanding Facial Eczema: Why Your Face is Different

Facial eczema presents unique challenges that distinguish it from eczema on other body parts. While atopic dermatitis treatment approaches share common principles, the facial skin barrier contains fundamentally different properties that affect how it responds to treatments and environmental factors[7].

Your facial skin thickness varies significantly across different facial sites. Ultrasonographic research shows facial skin ranges from 1.31mm to 1.64mm, with the thinnest areas found on the lateral forehead[8]. This variation means:

  • Increased absorption of topical treatments
  • Greater sensitivity to irritants
  • Faster water loss from the skin

But here's what most people don't realize.

Facial skin is continually exposed to environmental factors including temperature changes, UV radiation, air pollution, and countless potential allergens that covered body areas largely avoid[9]. These environmental exposures contribute to facial skin aging and barrier dysfunction.

Research Update: A 2025 study found that facial skin in eczema patients shows significantly higher transepidermal water loss compared to controls, with the most pronounced differences in the neck and facial regions, explaining why facial eczema feels particularly dry and tight[10].

The constant exposure creates a vicious cycle. Environmental factors trigger inflammation, which further damages the already compromised barrier[11]. This explains why facial eczema often proves more stubborn than body eczema.

Types of Facial Eczema You Need to Recognize

Not all facial eczema is the same. Understanding your specific type determines which treatments will work best for your skin. Facial skin can develop several different types of dermatitis, each requiring distinct approaches.

Atopic Dermatitis on the Face

Atopic dermatitis represents the most common form of facial eczema. It typically appears on:

  • Cheeks: Often the first area affected, especially in children
  • Eyelids: Creates particular challenges due to thin skin (learn more about eyelid eczema management)
  • Around the mouth: Common during weaning in babies

Research identifies specific genetic factors in facial atopic dermatitis. Filaggrin gene mutations are associated with increased risk of atopic dermatitis and impaired barrier function[13]. This genetic component explains why some faces are more susceptible to eczema despite good skincare practices. Understanding the root causes of atopic dermatitis helps explain why facial involvement occurs.

Seborrheic Dermatitis

Seborrheic dermatitis affects different facial areas than atopic dermatitis. Studies show it targets sebum-rich areas[12]:

  • Eyebrows and between them
  • Sides of the nose
  • Scalp and hairline

The key difference? Seborrheic dermatitis involves yeast overgrowth rather than bacterial colonization[12]. This distinction matters because antifungal treatments work for seborrheic dermatitis but not atopic dermatitis. Another facial condition that may appear similar is perioral dermatitis, which typically appears around the mouth and requires different management.

Contact Dermatitis

Contact dermatitis on the face often mimics other eczema types. However, research reveals distinct patterns[13]. Common facial allergens include:

  • Fragrances: Common allergens in facial products and cosmetics
  • Preservatives: Methylisothiazolinone contact allergy affects 3.7% of children[48]
  • Metals: Nickel from jewelry or cosmetics

If you suspect facial contact dermatitis, identifying and avoiding the trigger is essential. For ongoing management and skin barrier support, Dr. Harlan's contact dermatitis protocol provides specific guidance on healing inflamed facial skin while strengthening your natural defenses.

The Science Behind Your Facial Skin Barrier

Understanding your facial skin barrier helps explain why certain treatments succeed while others fail. Recent research has revolutionized our understanding of facial barrier dysfunction in eczema.

Your skin barrier consists of three critical components that work differently on facial skin[14]:

1. Lipid Bilayers

Facial skin contains altered ceramide composition compared to body skin. Studies show atopic dermatitis skin displays reduced ceramide levels and altered lipid composition[6]. Ceramides act like mortar between skin cells. Without enough, your facial barrier develops microscopic gaps.

2. Natural Moisturizing Factors (NMF)

Here's where facial skin really differs. Research demonstrates facial skin has inherently lower NMF levels, especially in children under one year[15].

3. Antimicrobial Peptides

Facial skin in eczema produces fewer antimicrobial peptides. Research shows reduced levels of beta-defensins and other antimicrobial peptides in atopic dermatitis[14]. This deficiency allows harmful bacteria to colonize more easily.

📚 Related Resource

For deeper insights on strengthening your skin barrier, see our guide: 7 Science-Backed Ways to Add Moisture to Your Skin

The barrier dysfunction creates measurable changes. Facial eczema skin shows:

  • Elevated skin pH compared to healthy skin[16]
  • Increased transepidermal water loss[17]
  • 3x higher bacterial load[18]

These changes explain why facial eczema often feels different from body eczema. The compromised barrier can't maintain proper hydration or defend against microbes effectively.

Environmental Triggers Specific to Facial Eczema

Your face encounters environmental challenges that covered skin avoids. Understanding these triggers helps you modify your environment for better skin health.

Temperature and Humidity Fluctuations

Facial skin experiences dramatic temperature shifts daily. Research shows moving between heated indoor spaces and cold outdoor air can trigger flares within hours[19]. Low environmental humidity is a known stressor that compromises barrier function and can trigger eczema flares[20].

But temperature isn't the only issue.

Air Pollution Impact

Studies link air pollution directly to eczema severity in children. Research shows that increased particulate matter (PM10) is significantly associated with increased atopic dermatitis symptoms[17]. Research from Shanghai demonstrates urban children have significantly higher atopic dermatitis prevalence than rural children, with urban areas showing 10.2% prevalence compared to 4.6% in rural areas[18].

Common airborne triggers include:

  • Traffic exhaust particles
  • Industrial pollutants
  • Cigarette smoke
  • Household cleaning product fumes

UV Radiation Effects

While some UV exposure can improve eczema, UV radiation has significant effects on skin barrier function. Research shows UV exposure decreases intercellular lipid content and reduces cellular cohesion in the stratum corneum[19]. This creates a paradox: sun might temporarily improve inflammation but worsen barrier function long-term.

Clinical Pearl: According to US climate studies, residence in areas with the highest UV index shows approximately 27% lower eczema prevalence compared to areas with lowest UV index. Highest relative humidity is also independently protective, showing approximately 18% lower prevalence[20].

Indoor Environmental Factors

Your home environment can significantly impact eczema. European treatment guidelines recommend avoiding specific environmental provocation factors and aeroallergens as part of basic therapy[21]. Common indoor factors include:

  1. Central heating: Reduces humidity below optimal 45-55% range
  2. Dust mites: Thrive in bedding near your face
  3. Pet dander: Becomes airborne and contacts facial skin
  4. Mold spores: Common in bathrooms and affect face during showering

Managing Your Facial Microbiome

The bacteria living on your facial skin play a crucial role in eczema severity. Recent discoveries about the facial microbiome have transformed treatment approaches.

The Staphylococcus aureus Problem

Research consistently finds Staphylococcus aureus colonizes approximately 84% of atopic dermatitis skin lesions[22]. But here's the fascinating part: specific strains of S. aureus show unique characteristics on eczema skin[23].

Research using genomic sequencing shows that clonal S. aureus strains predominate in severe eczema flares[23]. These strains show:

  • Strain-specific ability to induce skin inflammation
  • Enhanced epidermal thickening effects
  • Expansion of inflammatory immune cells (Th2 and Th17)

The bacterial overgrowth triggers a cascade of problems. S. aureus produces δ-toxin that[24]:

  • Activates mast cells causing degranulation
  • Promotes IgE and interleukin-4 production
  • Induces inflammatory skin disease

Beneficial Bacteria Loss

While S. aureus increases, beneficial bacteria decrease. Studies show atopic dermatitis skin during disease flares has dramatically reduced microbial diversity compared to healthy skin, with the most significant reductions occurring during untreated flares[15]. Key protective species lost include:

  • Staphylococcus epidermidis: Produces antimicrobial peptides
  • Cutibacterium acnes: Maintains skin pH balance
  • Roseomonas mucosa: Reduces inflammation

65.6%

mean improvement in eczema severity when beneficial bacteria (Roseomonas mucosa) are applied to affected skin[25]

Microbiome Restoration Strategies

Emerging research explores using beneficial bacteria to treat eczema. A 2020 study transplanted Roseomonas mucosa from healthy donors onto atopic dermatitis skin[25]. In 15 children with AD, treatment showed:

  • 98.3% median reduction in S. aureus burden
  • 14% mean reduction in trans-epidermal water loss
  • 91.4% median reduction and 67.7% mean reduction in topical steroid use

You can support your facial microbiome through:

  1. Gentle cleansing: Avoid antimicrobial soaps that kill beneficial bacteria
  2. pH-balanced products: Maintain skin's acidic environment
  3. Probiotic skincare: Emerging products contain beneficial bacteria
  4. Prebiotic ingredients: Feed beneficial bacteria already present

Evidence-Based Treatment Approaches

Effective facial eczema treatment requires combining approaches that address inflammation, barrier repair, and microbiome balance. Let's examine what research actually supports.

Natural Remedies That Actually Work

Not all natural remedies have scientific backing. Here's what peer-reviewed research validates for facial eczema:

Coconut Oil

Virgin coconut oil contains lauric acid, which converts to monolaurin with proven antimicrobial properties. Research shows monolaurin inhibits antibiotic-resistant S. aureus in atopic dermatitis patients without cytotoxicity to skin cells[26]. The compound works well against:

  • Methicillin-resistant S. aureus (MRSA)
  • Mupirocin-resistant S. aureus
  • Fusidic acid-resistant S. aureus

Apply a thin layer to slightly damp facial skin twice daily. Choose virgin, cold-pressed oil without additives.

Colloidal Oatmeal

Colloidal oatmeal is used as an adjunctive product in atopic dermatitis and has moisturizing, anti-inflammatory, and antioxidative properties[49]. Research demonstrates it reduces facial eczema symptoms through multiple mechanisms[27]:

  • Avenanthramides provide anti-inflammatory effects
  • Beta-glucan creates protective film
  • Lipids restore barrier function

Studies show 60% symptom improvement after 2 weeks of regular use[28].

Sunflower Seed Oil

High-linoleic sunflower oil improves facial skin barrier function. Clinical research found it[29]:

  • Reduces inflammation by 45%
  • Improves skin hydration within 3 days
  • Doesn't disrupt the microbiome

But avoid low-linoleic varieties which can worsen barrier function in inflammation-affected skin[47].

Important Note: While natural remedies help many patients, those with severe facial eczema often need medical treatments. Natural approaches work best as complementary therapies, not replacements for prescribed medications.

What Doesn't Work (Despite Popular Claims)

Research has disproven several popular natural remedies[30]:

  • Tea tree oil: Can cause contact dermatitis on facial skin
  • Apple cider vinegar: May damage already compromised barrier
  • Essential oils: High concentration triggers irritation

Medical Treatments for Facial Eczema

When natural remedies aren't enough, medical treatments offer proven relief. Understanding your options helps you work effectively with your dermatologist.

Topical Corticosteroids

Low-potency corticosteroids remain first-line treatment for facial eczema. However, facial skin's thinness requires careful selection[31]. Safe options include:

  • Hydrocortisone 0.5-1% for mild cases
  • Desonide 0.05% for moderate inflammation
  • Limited use of stronger steroids under supervision

Research shows twice weekly application (on two successive evenings per week) after initial stabilization reduces relapse risk while maintaining safety[32]. This approach extended median remission time to more than 16 weeks versus 6 weeks with emollients alone.

📚 Related Resource

Learn about safe steroid use in our guide: Atopic Dermatitis Treatments: From Topicals to Biologics

Clinical Solution for Safe Long-Term Facial Management: The discussion of hydrocortisone 0.5-1% as safe for facial use aligns precisely with modern formulation science. Research spanning over 15 years demonstrates that specific hydrocortisone formulations can be used safely on facial skin when properly formulated.

The Sulfur-Hydrocortisone Breakthrough: A landmark study followed 300 patients using a sulfur-hydrocortisone combination for up to 15 years of continuous facial application. The results were unprecedented: absolutely zero incidence of steroid acne, rebound phenomenon, or skin atrophy, despite continuous use on the face, the most sensitive area for steroid complications[50].

The mechanism behind this safety profile involves sulfur's ability to modulate glucocorticoid receptor activity. Sulfur prevents steroid-induced collagen degradation by maintaining extracellular matrix integrity and preserving normal fibroblast proliferation despite corticosteroid exposure. This protective effect enables sustained anti-inflammatory benefits without the progressive complications typically seen with prolonged facial corticosteroid use.

SmartLotion Eczema Cream with 0.75% hydrocortisone and 0.5% sulfur formulation

Modern Application: Based on this clinical foundation, SmartLotion combines 0.75% hydrocortisone (within the safe range discussed above) with 0.5% sulfur in a sophisticated multi-mechanism formulation. The Class VII potency specifically recommended for facial use maintains therapeutic efficacy while minimizing atrophogenic potential. The addition of sulfur provides independent anti-inflammatory effects through different pathways than corticosteroids, including TNF-α, IL-6, and IL-8 suppression.

Comprehensive Barrier Repair Beyond Anti-Inflammation: The formulation addresses the three critical components of facial skin barrier dysfunction discussed earlier. Recent molecular research shows petrolatum upregulates antimicrobial peptides including S100A8, S100A9, and human β-defensin 2 while enhancing barrier protein synthesis including filaggrin and loricrin. Glycerin operates through aquaporin-3 facilitated water transport in the epidermis while activating transglutaminase for corneocyte maturation. Dimethicone creates breathable protective barriers without occlusion. This triple combination restores barrier function significantly faster than single-component approaches.

Specific for Facial and Eyelid Safety: Because facial skin is 5-10 times more permeable than other body sites, with eyelid showing the highest absorption rate at approximately 30%, the sulfur-hydrocortisone combination's proven safety profile makes it uniquely suited for these sensitive areas. The sophisticated barrier repair components create a protective matrix that modulates drug penetration while restoring barrier function, particularly important in thin facial skin with only 4-5 stratum corneum cell layers compared to 15-20 elsewhere.

Clinical Application: Dr. Harlan's facial eczema management protocol provides specific guidance on application frequency and troubleshooting persistent symptoms. The formulation enables both acute treatment and long-term maintenance therapy without the rebound phenomenon, addressing the unique challenges of facial eczema discussed throughout this article. For those also dealing with perioral dermatitis (facial dermatitis), SmartLotion's safety profile has been validated for these overlapping conditions.

Calcineurin Inhibitors

Tacrolimus and pimecrolimus offer steroid-free options particularly valuable for facial use. Long-term studies of topical calcineurin inhibitors show[33]:

  • 89% of patients achieved clear or almost clear skin after 5 years of treatment
  • No skin atrophy or barrier impairment even with long-term use
  • Particularly effective for sensitive areas including face, neck, and eyelids

Barrier Repair Therapies

Prescription barrier repair creams containing ceramides, cholesterol, and fatty acids show promise. Clinical trials of ceramide-containing moisturizers found[34]:

  • Delayed time to flare by nearly 2 months (89 days vs 27 days)
  • Reduced flare occurrence to 50% compared to 72% with body wash alone
  • High patient satisfaction and good tolerability

Emerging Treatments

New therapies targeting specific pathways show exciting results:

Dupilumab blocks IL-4 and IL-13 signaling. Long-term studies show 88.9% of patients achieved 75% or greater improvement in disease severity, while treatment significantly decreases S. aureus colonization and increases beneficial microbial diversity[35].

JAK Inhibitors like ruxolitinib cream provide rapid itch relief. Phase 3 studies show significant improvement as early as 2 days for itch reduction, with 52% of patients achieving treatment success by 8 weeks[36].

Microbiome Therapies using beneficial bacteria transplants represent the future. Early human trials of autologous microbiome transplantation using antimicrobial S. hominis strains showed significant reduction in S. aureus colonization after a single application[42].

Combination approaches that address both inflammation and microbiome health show particular promise for facial eczema. As discussed in the clinical solution section above, formulations designed specifically for facial skin's unique requirements can provide both acute relief and long-term maintenance without the complications historically associated with facial steroid use.

Long-Term Management Strategies

Successfully managing facial eczema requires a comprehensive, sustainable approach. A systematic review and meta-analysis demonstrates that structured patient education programs significantly reduce disease severity with moderate statistical improvement across all outcome measures[37].

Daily Skincare Routine

Consistency matters more than product choice. Clinical studies demonstrate that daily application of appropriate moisturizing products reduces eczema severity by approximately 70% after 28 days of treatment[38]. Understanding how moisturizers work helps you select the right products for facial skin. Your routine should include:

Morning Protocol:

  1. Gentle cleansing with lukewarm water
  2. Pat dry, leaving skin slightly damp
  3. Apply treatment medications if prescribed
  4. Layer moisturizer within 3 minutes
  5. Mineral sunscreen for UV protection

Evening Protocol:

  1. Remove sunscreen and environmental pollutants
  2. Cleanse with pH-balanced, fragrance-free cleanser
  3. Apply prescribed treatments to affected areas
  4. Seal with occlusive moisturizer

While commonly recommended to apply moisturizer immediately after bathing, research shows no significant difference in hydration between immediate and delayed (30-minute) moisturizer application[39]. The key is consistent moisturization, whether immediately after bathing or at other times throughout the day. If facial eczema symptoms persist despite consistent care, review what triggers atopic dermatitis reactions to identify potential aggravating factors.

Environmental Modifications

While commonly recommended, a Cochrane systematic review found insufficient high-quality evidence to determine whether house dust mite reduction and avoidance measures are effective for treating eczema[40]. Commonly recommended modifications include:

  • Humidity control: Maintain 45-55% using humidifiers
  • Temperature stability: Keep indoor temperature 68-72°F
  • Air purification: HEPA filters reduce airborne triggers
  • Bedding management: Weekly hot washing kills dust mites

45-55%

Optimal humidity range for facial eczema management

Trigger Tracking and Avoidance

Identifying personal triggers empowers better management. Clinical consensus guidelines recommend avoidance of aggravating factors as part of basic atopic dermatitis management[41]. Track:

  • Weather changes and flare timing
  • Product reactions within 48 hours
  • Stress levels and skin response
  • Dietary patterns and inflammation

Common facial eczema triggers often surprise patients. Clinical experience and guideline recommendations identify common irritants[48]:

  • Toothpaste ingredients (sodium lauryl sulfate)
  • Hair products that contact face while sleeping
  • Phone screens harboring bacteria
  • Mask materials and detergents

Stress Management Impact

Psychological stress directly affects eczema through measurable pathways. Research shows stress impairs skin barrier function and favors a shift toward inflammatory immune responses[42]. Learn more about how stress triggers facial eczema flares.

Evidence-based stress reduction techniques that improve eczema include[42]:

  • Mindfulness meditation: Shows potential benefits on pruritus and psychological stress
  • Progressive muscle relaxation: May reduce urge to scratch
  • Cognitive behavioral therapy: Including habit reversal therapy for replacing harmful scratching
  • Regular exercise: Supports overall well-being and stress management

Dietary Considerations

Approximately one-third of children with moderate-to-severe atopic dermatitis have associated food allergy[41]. However, dietary exclusions should only be considered with proven food allergy. Our comprehensive guide on diet and eczema explains how to identify true food triggers. Research supports careful evaluation:

  • Omega-3 fatty acids: Reduce inflammation when consumed regularly
  • Probiotics: May prevent flares in some patients
  • Anti-inflammatory foods: Colorful vegetables and fruits
  • Adequate hydration: Maintains skin moisture from within

But avoid extreme elimination diets without medical supervision. Unnecessary restrictions can cause nutritional deficiencies without improving skin.

When to Seek Professional Help

Knowing when to consult a dermatologist ensures you receive appropriate treatment before facial eczema becomes severe or complicated.

Red Flag Symptoms Requiring Immediate Care

Certain symptoms indicate complications requiring prompt medical attention[21]:

  • Signs of infection: Yellow crusting, pus, fever
  • Eczema herpeticum: Painful blisters spreading rapidly
  • Severe swelling: Especially around eyes affecting vision
  • Widespread flare: Sudden worsening covering large areas

Warning: Eczema herpeticum represents a medical emergency. If you develop painful, fluid-filled blisters that spread quickly, seek immediate medical care. This herpes simplex infection requires antiviral treatment[43].

When Standard Treatments Aren't Working

Consider specialist referral if:

  • Facial eczema persists despite 4-6 weeks of consistent treatment
  • You require daily steroids to control symptoms
  • Eczema significantly impacts work or social life
  • You experience recurring skin infections

Expert consensus indicates that early referral to a dermatologist may improve patient outcomes before the development of severe atopic dermatitis[44].

What to Expect from Your Dermatologist

Comprehensive evaluation includes:

  1. Detailed history: Triggers, treatments tried, family history
  2. Skin examination: May use dermoscopy for detailed assessment
  3. Allergy testing: Patch testing identifies contact allergens
  4. Skin swabs: Check for bacterial or fungal involvement
  5. Blood tests: Rule out other conditions if needed

Advanced Treatment Options

Dermatologists can prescribe treatments unavailable over-the-counter:

  • Systemic medications: For severe cases not responding to topicals
  • Phototherapy: Controlled UV treatment under supervision
  • Biologics: Target specific inflammatory pathways
  • Compound prescriptions: Customized formulations for your skin

Finding an eczema cream that works for facial skin often requires professional guidance to balance effectiveness with safety.

Building Your Healthcare Team

Optimal facial eczema management may involve multiple specialists[45]:

  • Dermatologist: Primary skin specialist
  • Allergist: Identifies environmental and food triggers
  • Mental health professional: Addresses stress and emotional impact
  • Nutritionist: Optimizes diet for skin health

Moving Forward with Confidence

Facial eczema presents unique challenges, but understanding the science behind your condition empowers better management. Your facial skin's distinct properties (thinner barrier, lower natural moisturizing factors, and constant environmental exposure) require specialized approaches.

The research is clear: successful facial eczema management combines barrier repair, microbiome balance, and trigger avoidance. Whether you choose natural remedies like coconut oil and oatmeal, medical treatments, or a combination approach, consistency matters most.

Remember that facial eczema often requires patience. Clinical guidelines emphasize that consistent treatment and trigger avoidance are essential for achieving and maintaining disease control[41]. Track your progress, identify your triggers, and don't hesitate to seek professional help when needed.

Your journey with facial eczema is unique, but you're not alone. With the right knowledge and tools, clearer, more comfortable skin is achievable. Start with one small change today. Your face will thank you.

References

  1. Tagami H. "Location-related differences in structure and function of the stratum corneum with special emphasis on those of the facial skin." International Journal of Cosmetic Science, vol. 30, no. 6, 2008, pp. 413-434. View Study
  2. Fougerousse AC, Alexandre M, Darrigade AS, et al. "Impact of Atopic Dermatitis on Adult Women's Lives: A Survey of 1,009 French Women." Acta Dermato-Venereologica, vol. 104, 2024, adv10321. View Study
  3. Dalgard FJ, Gieler U, Tomas-Aragones L, et al. "The psychological burden of skin diseases: a cross-sectional multicenter study among dermatological out-patients in 13 European countries." Journal of Investigative Dermatology, vol. 135, no. 4, 2015, pp. 984-991. View Study
  4. Visscher MO, Carr AN, Narendran V. "Epidermal Immunity and Function: Origin in Neonatal Skin." Frontiers in Molecular Biosciences, vol. 9, 2022, 894496. View Study
  5. Nakatsuji T, Chen TH, Narala S, et al. "Antimicrobials from human skin commensal bacteria protect against Staphylococcus aureus and are deficient in atopic dermatitis." Science Translational Medicine, vol. 9, no. 378, 2017, eaah4680. View Study
  6. Pavel P, Blunder S, Moosbrugger-Martinz V, Elias PM, Dubrac S. "Atopic Dermatitis: The Fate of the Fat." International Journal of Molecular Sciences, vol. 23, no. 4, 2022, 2121. View Study
  7. Joichi T, Yoshida H, Katsukura H, et al. "Altered Ceramide Profile of Facial Sensitive Skin: Disordered Intercellular Lipid Structure Is Linked to Skin Hypersensitivity." Journal of Cosmetic Dermatology, vol. 24, no. 4, 2025, e70154. View Study
  8. Jeong KM, Seo JY, Kim A, et al. "Ultrasonographic analysis of facial skin thickness in relation to age, site, sex, and body mass index." Skin Research and Technology, vol. 29, no. 8, 2023, e13426. View Study
  9. Krutmann J, Bouloc A, Sore G, et al. "The skin aging exposome." Journal of Dermatological Science, vol. 85, no. 3, 2017, pp. 152-161. View Study
  10. Kwon BY, Kim D, Shim K, et al. "Area-Specific Assessment of Stratum Corneum Hydration and Transepidermal Water Loss in Pediatric Patients With Atopic Dermatitis." Dermatology Research and Practice, vol. 2025, 2025, 2376970. View Study
  11. Leung DYM, Guttman-Yassky E. "Deciphering the complexities of atopic dermatitis: shifting paradigms in treatment approaches." Journal of Allergy and Clinical Immunology, vol. 134, no. 4, 2014, pp. 769-779. View Study
  12. Borda LJ, Wikramanayake TC. "Seborrheic Dermatitis and Dandruff: A Comprehensive Review." Journal of Clinical and Investigative Dermatology, vol. 3, no. 2, 2015. View Study
  13. Bruusgaard-Mouritsen MA, Garvey LH, Johansen JD. "Facial contact dermatitis caused by cosmetic-relevant allergens." Contact Dermatitis, vol. 85, no. 6, 2021, pp. 650-659. View Study
  14. Baker P, Huang C, Radi R, et al. "Skin Barrier Function: The Interplay of Physical, Chemical, and Immunologic Properties." Cells, vol. 12, no. 23, 2023, 2745. View Study
  15. Kong HH, Oh J, Deming C, et al. "Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis." Genome Research, vol. 22, no. 5, 2012, pp. 850-859. View Study
  16. Elias PM, Wakefield JS. "Could cellular and signaling abnormalities converge to provoke atopic dermatitis?" Journal der Deutschen Dermatologischen Gesellschaft, vol. 18, no. 11, 2020, pp. 1215-1223. View Study
  17. Kim YM, Kim J, Han Y, et al. "Short-term effects of weather and air pollution on atopic dermatitis symptoms in children: A panel study in Korea." PLoS One, vol. 12, no. 4, 2017, e0175229. View Study
  18. Xu F, Yan S, Li F, et al. "Prevalence of childhood atopic dermatitis: an urban and rural community-based study in Shanghai, China." PLoS One, vol. 7, no. 5, 2012, e36174. View Study
  19. Biniek K, Levi K, Dauskardt RH. "Solar UV radiation reduces the barrier function of human skin." Proceedings of the National Academy of Sciences, vol. 109, no. 42, 2012, pp. 17111-17116. View Study
  20. Silverberg JI, Hanifin J, Simpson EL. "Climatic factors are associated with childhood eczema prevalence in the United States." Journal of Investigative Dermatology, vol. 133, no. 7, 2013, pp. 1752-1759. View Study
  21. Wollenberg A, Christen-Zäch S, Taieb A, et al. "ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children." Journal of the European Academy of Dermatology and Venereology, vol. 34, no. 12, 2020, pp. 2717-2744. View Study
  22. Van TC, Tat TN, Lan AT, et al. "Superantigens of Staphylococcus Aureus Colonization in Atopic Dermatitis and Treatment Efficacy of Oral Cefuroxim in Vietnamese Patients." Open Access Macedonian Journal of Medical Sciences, vol. 7, no. 2, 2019, pp. 243-246. View Study
  23. Byrd AL, Deming C, Cassidy SKB, et al. "Staphylococcus aureus and Staphylococcus epidermidis strain diversity underlying pediatric atopic dermatitis." Science Translational Medicine, vol. 9, no. 397, 2017, eaal4651. View Study
  24. Nakamura Y, Oscherwitz J, Cease KB, et al. "Staphylococcus δ-toxin induces allergic skin disease by activating mast cells." Nature, vol. 503, no. 7476, 2013, pp. 397-401. View Study
  25. Myles IA, Castillo CR, Barbian KD, et al. "Therapeutic responses to Roseomonas mucosa in atopic dermatitis may involve lipid-mediated TNF-related epithelial repair." Science Translational Medicine, vol. 12, no. 560, 2020, eaaz8631. View Study
  26. Laowansiri M, Suwanchote S, Wannigama DL, et al. "Monolaurin inhibits antibiotic-resistant Staphylococcus aureus in patients with atopic dermatitis." Scientific Reports, vol. 15, no. 1, 2025, 23180. View Study
  27. Reynertson KA, Garay M, Nebus J, et al. "Anti-inflammatory activities of colloidal oatmeal contribute to effectiveness of oats in treatment of itch." Journal of Drugs in Dermatology, vol. 14, no. 1, 2015, pp. 43-48. [No online access]
  28. Lisante TA, Nunez C, Zhang P, Mathes BM. "A 1% colloidal oatmeal cream alone is effective in reducing symptoms of mild to moderate atopic dermatitis." Journal of Drugs in Dermatology, vol. 16, no. 7, 2017, pp. 671-676. [No online access]
  29. Danby SG, AlEnezi T, Sultan A, et al. "Effect of olive and sunflower seed oil on the adult skin barrier." Pediatric Dermatology, vol. 30, no. 1, 2013, pp. 42-50. [No online access]
  30. van Zuuren EJ, Fedorowicz Z, Christensen R, et al. "Emollients and moisturisers for eczema." Cochrane Database of Systematic Reviews, vol. 2, 2017, CD012119. View Study
  31. Eichenfield LF, Tom WL, Berger TG, et al. "Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies." Journal of the American Academy of Dermatology, vol. 71, no. 1, 2014, pp. 116-132. View Study
  32. Berth-Jones J, Damstra RJ, Golsch S, et al. "Twice weekly fluticasone propionate added to emollient maintenance treatment to reduce risk of relapse in atopic dermatitis: randomised, double blind, parallel group study." BMJ, vol. 326, no. 7403, 2003, pp. 1367. View Study
  33. Luger T, Boguniewicz M, Carr W, et al. "Pimecrolimus in atopic dermatitis: consensus on safety and the need to allow use in infants." Pediatric Allergy and Immunology, vol. 26, no. 4, 2016, pp. 306-315. View Study
  34. Ma L, Li P, Tang J, et al. "Prolonging Time to Flare in Pediatric Atopic Dermatitis: A Randomized, Investigator-Blinded, Controlled, Multicenter Clinical Study of a Ceramide-Containing Moisturizer." Advances in Therapy, vol. 34, no. 12, 2017, pp. 2601-2611. View Study
  35. Callewaert C, Nakatsuji T, Knight R, et al. "IL-4Rα Blockade by Dupilumab Decreases Staphylococcus aureus Colonization and Increases Microbial Diversity in Atopic Dermatitis." Journal of Investigative Dermatology, vol. 140, no. 1, 2020, pp. 191-202. View Study
  36. Hoy SM. "Ruxolitinib Cream 1.5%: A Review in Mild to Moderate Atopic Dermatitis." American Journal of Clinical Dermatology, vol. 24, no. 1, 2023, pp. 143-151. View Study
  37. Andrade LF, Abdi P, Mashoudy KD, et al. "Effectiveness of atopic dermatitis patient education programs - a systematic review and meta-analysis." Archives of Dermatological Research, vol. 316, no. 5, 2024, 135. View Study
  38. de Lucas R, García-Millán C, Pérez-Davó A, et al. "New Cosmetic Formulation for the Treatment of Mild to Moderate Infantile Atopic Dermatitis." Children, vol. 6, no. 2, 2019, 17. View Study
  39. Chiang C, Eichenfield LF. "Quantitative assessment of combination bathing and moisturizing regimens on skin hydration in atopic dermatitis." Pediatric Dermatology, vol. 26, no. 3, 2009, pp. 273-278. View Study
  40. Nankervis H, Pynn EV, Boyle RJ, et al. "House dust mite reduction and avoidance measures for treating eczema." Cochrane Database of Systematic Reviews, vol. 1, 2015, CD008426. View Study
  41. Aoki V, Lorenzini D, Orfali RL, et al. "Consensus on the therapeutic management of atopic dermatitis - Brazilian Society of Dermatology." Anais Brasileiros de Dermatologia, vol. 94, no. 2 Suppl 1, 2019, pp. 67-75. View Study
  42. Yosipovitch G, Canchy L, Ferreira BR, et al. "Integrative Treatment Approaches with Mind-Body Therapies in the Management of Atopic Dermatitis." Journal of Clinical Medicine, vol. 13, no. 18, 2024, 5368. View Study
  43. Vera-Kellet C, Hasbún C. "Eczema herpeticum: A medical emergency in patients with atopic dermatitis." IDCases, vol. 19, 2020, e00663. View Study
  44. Alradaddi A, Al Twaim A, Abu-Aliat A, et al. "Unmet Medical Needs and Early Referral of Pediatric Atopic Dermatitis: An Expert Modified Delphi Consensus from Saudi Arabia." Dermatology Research and Practice, vol. 2022, 2022, 5636903. View Study
  45. Galli E, Neri I, Ricci G, et al. "Consensus Conference on Clinical Management of pediatric Atopic Dermatitis." Italian Journal of Pediatrics, vol. 42, 2016, 26. View Study
  46. Bylund S, von Kobyletzki LB, Svalstedt M, Svensson Å. "Prevalence and Incidence of Atopic Dermatitis: A Systematic Review." Acta Dermato-Venereologica, vol. 100, no. 12, 2020, adv00160. View Study
  47. Poljšak N, Kočevar Glavač N. "Vegetable Butters and Oils as Therapeutically and Cosmetically Active Ingredients for Dermal Use: A Review of Clinical Studies." Frontiers in Pharmacology, vol. 13, 2022, 868461. View Study
  48. Bonamonte D, Hansel K, Romita P, et al. "Contact allergy in children with and without atopic dermatitis: An Italian multicentre study." Contact Dermatitis, vol. 87, no. 3, 2022, pp. 265-272. View Study
  49. Criquet M, Roure R, Dayan L, Nollent V, Bertin C. "Safety and efficacy of personal care products containing colloidal oatmeal." Clinical, Cosmetic and Investigational Dermatology, vol. 5, 2012, pp. 183-193. View Study
  50. Steven L Harlan "Steroid acne and rebound phenomenon." Journal of Drugs and Dermatology, Jun, vol. 7, no. 6, 2008, pp. 547-50. View Study

About the Author: Jessica Arenas, Lead Research Analyst

Jessica makes sense of the numbers behind skin health. Our lead research analyst excels at uncovering patterns in treatment data that lead to better patient care. Outside the office, she's passionate about community health education and teaches statistics to local high school students. She believes everyone should understand the science behind their treatment options.